Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
March 07, 2022 09:25 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food &...
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
February 24, 2022 16:05 ET
|
Merit Medical Systems, Inc.
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020Q4 2021 GAAP EPS increased 32% year-over-year to...
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
January 17, 2022 16:55 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...
Merit Medical Announces Agreement in Principle to Settle Class Action Litigation
November 23, 2021 09:25 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional,...
Merit Medical Reports Results For Quarter Ended September 30, 2021
October 28, 2021 16:05 ET
|
Merit Medical Systems, Inc.
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share...
Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
October 05, 2021 17:47 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
September 20, 2021 09:25 ET
|
Merit Medical Systems, Inc.
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a...
Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard
August 16, 2021 16:05 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in...
Merit Medical Reports Results for Quarter Ended June 30, 2021
July 29, 2021 16:05 ET
|
Merit Medical Systems, Inc.
Q2 2021 reported revenue of $280.3 million, up 28.4% compared to Q2 2020Q2 2021 constant currency revenue, organic* up 25.5% compared to Q2 2020Q2 2021 GAAP EPS of $0.09, compared to GAAP loss per...
Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
July 09, 2021 16:05 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...